2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

News provided by

Feb 13, 2013, 02:35 ET

NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

http://www.reportlinker.com/p01095481/2013-Analysis-of-the-Global-Cancer-Diagnostics-Market-Emerging-Tests-Technology-Assessment-Instrumentation-Review-Sales-Forecasts-by-Country-and-Strategic-Profiles-of-Leading-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.

Table of Contents

II. Worldwide Market Structure

III. Major Current And Emerging Cancer Diagnostic Tests

1. Introduction2. Tumor Marker Classification3. ACTH4. Alpha-Fetoprotein (AFP)5. Beta-2 Microglobulin6. CA 15-3/27.297. CA 19-98. CA-1259. Calcitonin10. Carcinoembrionic Antigen (CEA)11. Estrogen and Progesterone Receptors12. Ferritin13. Gastrin14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor Markers- ADA- B-Protein- PNP- 5'-Nucleotidase 27. Oncogenes- Abl/abl-bcr- AIB1- BCL-2- BRCA1- CD44- C-fos- C-myb- C-myc- CYP-17- Erb-B- HPC1- N-myc- P40- P51- P53- PIK3CA- PTI-1- Ras- Reg- Sis- Src28. Polypeptide Growth Factors- Basic Fibroblast Growth Factor- Beta-TGF- Cachectin (TNT)- Calmodulin- ECFR- Nerve Growth Factor (NGF)- Epidermal Growth Factor (EGF)- Ornithine Decarboxylase- Transferrin- Transforming Growth Factor-Alpha 29. Ectopic Hormones30. Colony Stimulating Factors31. Lymphokines- Alpha-Interferon- B Cell Growth Factors- B Cell Growth Factor (BCGF)- Gamma-Interferon- Interleukin-1 (IL-1)- Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor Markers- N-Acetylglucosamine- Actin- Alpha-Actin - Antineuronal Antibodies- 7B2- B72.3- Bax- BCD-F9- BLCA-4- Blood Group Antigens A,B,H- CA 50- CA 72-4/TAG-72- CA 195- CA-242- CA-549- CAM 26- CAR-3- Cathepsin-D- Chromogranin A and B- Cluster 1 Antigen- Cluster-5/5A Antigen- CTA- CU18- DR-70- DU-PAN-2- Endometrial Bleeding Associated Factor- Endostatin- Epithelial Membrane Antigen- Feulgen Hydrolysis- Fibronectin- FSH- (1->3)-L-fucosyltransferase- Gastrin-Releasing Peptide (GRP)- GDCFP-15- Glucagon- Glycoamines- H23- Her-2- Human Carcinoma Antigen- HPA- HSP27- Intermediate Filaments- Cytokeratins/CK18/Cyfra 21-1- Desmin- Gliofibrillary Acid Protein- Neurofilaments- Vimentin- KA 93- Kinases- KP16D3- LAI- Leukocyte Common Antigen- Lewis Antigens- Lysophosphatidic Acid (LPA)- Ma 695/Ma 552- MABDF3- MAG- ME1- Minactivin- MN/CA9- MSA- Mucin Cancer Antigen (MCA)- Multiple Tumor Suppressor 1- Myosin- NEA-130- NMP22- OA-519- Opiod Peptides- P-glycoprotein- Pancreatic Oncofetal Antigen (POA)- Placental Lactogen- PR92- Proliferative Index, Ki-67- Px- RB Inactivation/Deletion- Ret- SCCL 175- Selectin- Sialic Acid- Sialyl SSEA-1/SLX- SN10- Somatostatin- TA-90- TABA- Tachykinin- TAG 12- TPS- Troponin- Tubulin- VCAM- VEGF- Villen

IV. Instrumentation Review:

Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Horiba, Inverness/Alere, J&J, Olympus, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers

V. Current and Emerging Technologies

1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)- Overview- ELISA- Immunofiltration- Particle-Membrane Capture Immunoassay- Enzyme Amplificationd. Fluorescent Immunoassayse. Luminescence- Chemiluminescence- Bioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3. Molecular Diagnosticsa. Technology Overviewb. Amplification Methods- PCR- DAP-PCR- Immuno-PCR- QC-PCR- CAR- DNA- HPA- LCR- NASBA- QBR- SDA- 3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)d. Malignant Lymphomas Lymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics Spectroscopy

VI. Competitive Profiles

- Abbott- AdnaGen- Applied Gene Technologies- Beckman Coulter/Danaher- Becton Dickinson- Biomedical Diagnostics- bioMerieux- Bio-Rad- CellSearch- Cepheid- Dako- Decode- Diadexus- Diagnocure- Diasorin- Eiken Chemical- Enterix- Enzo Biochem- Epigenomics- Exact Sciences- Fujirebio- Gen-Probe- Guided Therapeutics- Hologic- Kreatech- Kyowa Medex- Life Technologies- Mackay Life Sciences- Myriad Genetics- Nanogen Elitech- Nuvelo- OncoLab- Ortho-Clinical Diagnostics- Panacea Pharmaceuticals- Polartechnics- Polymedco- PreMD- Qiagen/Ipsogen- Radient Pharmaceuticals- Roche- Scienion- Sequenom- Siemens Healthcare- Takara Bio- Targeted Diagnostics & Therapeutics- Tosoh - Vermillion/Correlogic Systems- Wako Pure Chemicals- Wallac/PE- Zila

Appendixes: Major Universities and Research Centers Developing

Cancer Diagnostic Technologies and Applications

List of Tables

Tumor Marker Classification